Enzolytics Inc (ENZC)

[foxi]

Just watched the interview! Some cliffnotes & DD:


Interview link:

18:00 IPF Immune: have partnered with NPI for sales, marketing, logistics, regulatory compliance. Will be launching on "multiple big and small retail chains, online platforms, in March 2022." (Including Amazon) Production "has been completed" in Europe, ready with marketing campaigns. Will be launching a website dedicated to IPF Immune (testimonials, reviews, buy direct) that's separate from ENZC's main website.

21:32 "On track" for "introducing" ITV-1 to Africa in late March early April. Working with Scendea for FDA and EMA approval processes. New development: planning to introduce ITV-1 to both North America and Europe at the same time.

27:27 Audit "remains our #1 priority". Brought in accounting firm, "fulfilled all the requirements". Will be submitting audit in hope to be uplisted in 'days to weeks'. (How long does uplisting take? I think usually about 4 weeks for OTCQB pre-covid. Not sure if they need to submit another quarterly or annual report as well.)

29:11 mAbs for HIV and SARS-COV-2 "the work that we're doing is progressing well". Confident hiv primate study will be a success because in Fauci's primate study (early 2000s) using KLVC which is "exactly similar" to the epitope ENZC is using called KLIC, "the primate was cured". Thus there is a "precedent for success" and ENZC is "100% confident" they will achieve success with their own primate study. See also http://www.bioclonetics.com/validation.html (This was in answer to "when", so it was a non-answer.)

30:22 Communicated about hiv mAb program with Gilead and Viiv about HIV mAbs, received "tremendous interest". These companies "provided certain milestones" that ENZC needs to complete before they'd consider partnership. Chandra on the timeline: "we are progressing very well as we go ahead and share the data that we've been generating" (No "when", also I heard Viiv and not Eli Lilly)


Variables not addressed in the interview:
- At least three active lawsuits. Remember it's been speculated that some of the lawsuits (disputes about shares) are what's holding up the audit. https://imkingofprussia.com/cases-im-following/
- Are there ongoing debt conversions or some party still dumping large numbers of shares?


Godfather's summary:

1- IPF marketing campaign w/ TV Commercials. US Sales start in March 2022
2- ITV1 production and Africa Sales start in March/April, 2022
3- Diagnostics/Prognostics patent!
4- Tremendous Interest from #Gilead and #EliLilly on HIV mAbs Results

$ENZC 🎙INTERVIEW🎙

1️⃣ IPF marketing campaign w/ TV Commercials. US Sales start in March 2022 💥
2️⃣ ITV1 production and Africa Sales start in March/April, 2022
3️⃣ Diagnostics/Prognostics patent!
4️⃣ Tremendous Interest from #Gilead and #EliLilly on HIV mAbs Results 💥

Part 1. https://t.co/oSZrmV5FZT

— 𝐆𝐨𝐝𝐟𝐚𝐭𝐡𝐞𝐫 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 (@GodfatherCap) January 25, 2022